Yue-mei M. Hu
Purple Mountain Observatory, Key Laboratory Of Dark Matter And Space Astronomy
Nanjing, 210023, China
Nanjing, 210023, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Observation of a Spectral Hardening in Cosmic Ray Boron Spectrum with the DAMPE Space Mission.
Journal: Physical review letters
Published: December 17, 2024
Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial.
Journal: The Lancet regional health. Western Pacific
Published: February 06, 2023
Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial.
Journal: The Lancet. Infectious diseases
Published: April 18, 2022
Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trials.
Journal: Vaccine
Published: December 21, 2021
Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response.
Journal: Emerging microbes & infections
Published: February 15, 2021
Spatial-temporal trend of grassland net primary production and their driving factors in the Loess Plateau, China
Journal: Ying yong sheng tai xue bao = The journal of applied ecology
Published: January 21, 2021
Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis.
Journal: Expert review of vaccines
Published: January 12, 2021
Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study.
Journal: Human vaccines & immunotherapeutics
Published: December 03, 2020
Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals.
Journal: Human vaccines & immunotherapeutics
Published: June 17, 2020
Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial.
Journal: Human vaccines & immunotherapeutics
Published: November 27, 2019
Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women.
Journal: Science China. Life sciences
Published: March 12, 2019
Last Updated: 09/26/2026